[EW] Edwards Lifesciences Corporation


Type of security: Stock

Sector: Health Care

Industry: Industrial Specialties

Market Capitalization: 22.66 B

Exchange: NYSE

The data is delayed by 15 minutes.


Price: 93 Change: 1.21 (1.32%)
Ext. hours: Change: 0 (0%)

chart EW

Refresh chart

Strongest Trends Summary For EW

EW is in the medium-term up 22% above S&P in 1 year. In the long-term up 42% above S&P in 2 years and up 264% above S&P in 8 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient?s diseased or defective heart valve; and produces pericardial valves from biologically inert animal tissue. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae that is used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patie

Fundamental Ratios
Shares Outstanding211.76 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 1.55% Sales Growth - Q/Q4.49% P/E
P/E To EPS Growth P/S9.32 P/BV9.9 Price/Cash Per Share16.09
Price/Free Cash Flow24.13 ROA12.19% ROE19.22% ROI13.91%
Current Ratio5.16 Quick Ratio4.46 Long Term Debt/Equity0.32 Debt Ratio0.19
Gross Margin74.38% Operating Margin23.69% Net Profit Margin18.08% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-122.5 M Cash From Investing Activities-167.8 M Cash From Operating Activities243.4 M Gross Profit458.2 M
Net Profit112.7 M Operating Profit142.2 M Total Assets3.61 B Total Current Assets2.3 B
Total Current Liabilities445.2 M Total Debt600.3 M Total Liabilities1.32 B Total Revenue616.8 M
Technical Data
High 52 week192.15 Low 52 week127.36 Last close174.33 Last change-1.02%
RSI28.21 Average true range4.89 Beta0.63 Volume1.17 M
Simple moving average 20 days-5.68% Simple moving average 50 days-3.82% Simple moving average 200 days9.22%
Performance Data
Performance Week-2.21% Performance Month-7.64% Performance Quart3.56% Performance Half24.2%
Performance Year34.5% Performance Year-to-date13.81% Volatility daily1.71% Volatility weekly3.81%
Volatility monthly7.81% Volatility yearly27.07% Relative Volume162.97% Average Volume1.32 M
New High New Low


2019-06-14 16:29:35 | Why This Method Of Replacing A Faulty Heart Valve Is Gaining Steam

2019-06-13 09:36:04 | Read This Before Buying Edwards Lifesciences Corporation NYSE:EW Shares

2019-06-13 09:30:01 | HOLX or EW: Which Is the Better Value Stock Right Now?

2019-06-11 08:02:33 | See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.

2019-06-10 08:04:46 | See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.

2019-06-07 08:26:12 | DexCom and Companion Medical Collaboration to Support CGM

2019-06-04 11:00:00 | Edwards Lifesciences To Present At The Goldman Sachs 40th Annual Global Healthcare Conference

2019-06-04 07:45:58 | The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-tender Offer

2019-06-03 16:15:00 | Edwards Lifesciences Recommends Stockholders Reject _Mini-Tender Offer_ By TRC Capital Corporation

2019-05-29 11:38:56 | Why We Like Edwards Lifesciences Corporation’s NYSE:EW 23% Return On Capital Employed

2019-05-23 09:30:01 | Why Is Edwards Lifesciences EW Down 2.9% Since Last Earnings Report?

2019-05-22 02:30:00 | Edwards Announces Milestones For Transcatheter Mitral Program

2019-05-20 09:30:01 | HOLX vs. EW: Which Stock Is the Better Value Option?

2019-05-15 09:15:00 | Edwards Lifesciences' Every Heartbeat Matters Charitable Initiative On Track to Impact 1.5 Million Underserved People By 2020

2019-05-15 05:34:09 | Bull of the Day: Penumbra PEN

2019-05-13 20:15:02 | Edwards Lifesciences Corp EW Chairman & CEO Michael A Mussallem Sold $5.9 million of Shares

2019-05-10 07:52:07 | Investors Who Bought Edwards Lifesciences NYSE:EW Shares Five Years Ago Are Now Up 314%

2019-05-07 08:15:00 | Favorable Study Outcomes Presented On Edwards Aortic Valves With RESILIA Tissue

2019-05-07 08:03:13 | See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.

2019-05-01 10:26:02 | Masimo Gets CE Mark for ANI Module, Enhances Root Platform

2019-05-01 10:05:00 | Edwards Lifesciences To Webcast Annual Meeting Of Stockholders

2019-04-30 20:15:03 | Edwards Lifesciences Corp EW Chairman & CEO Michael A Mussallem Sold $5.7 million of Shares

2019-04-26 17:47:53 | 5 Peter Lynch Stalwarts With Strong Operating Margins

2019-04-25 04:10:08 | Edwards Lifesciences EW Q1 Earnings Beat, EPS View Raised

2019-04-25 00:33:55 | Edited Transcript of EW earnings conference call or presentation 23-Apr-19 9:00pm GMT

2019-04-24 17:24:38 | Medtech Stock Skids On Its 'Off-Color Performance' Following FDA Jabs

2019-04-24 11:22:01 | Analysts Shrug Off Softness In Edwards Lifesciences' Heart Value Replacement System

2019-04-24 09:08:00 | EBay Stock Gains, Edwards Lifesciences Falls, and 3 More Wednesday Movers

2019-04-23 23:29:58 | Dow Jones Futures: Stock Market Rally At Tipping Point; 5 Big Earnings Movers

2019-04-23 23:14:50 | Edwards Lifesciences Corp EW Q1 2019 Earnings Call Transcript

2019-04-23 17:29:24 | This Medical Giant Beat Forecasts, But It's Losing Share In A Key Area

2019-04-23 16:39:29 | Edwards Lifesciences: 1Q Earnings Snapshot

2019-04-23 16:15:00 | Edwards Lifesciences Reports First Quarter Results

2019-04-23 11:35:52 | What You Must Know About Edwards Lifesciences Corporation's NYSE:EW Financial Health

2019-04-23 08:08:52 | The Daily Biotech Pulse: FDA Accepts Alder's Migraine Drug Application, Gritstone Offering, Lilly's Chinese Sale

2019-04-22 16:18:45 | Earnings From Twitter, Lockheed And These Top Stocks: Action Plan

2019-04-22 08:28:12 | Edwards Lifesciences Takes Over CAS Medical Systems for $100M

2019-04-19 09:15:01 | So Far, So Good for Earnings Season

2019-04-18 16:15:00 | Edwards Lifesciences Completes Acquisition of CASMED

2019-04-17 09:58:01 | What's in Store for Edwards Lifesciences' EW Q1 Earnings?

2019-04-16 10:31:02 | Edwards Lifesciences EW Earnings Expected to Grow: Should You Buy?

2019-04-15 17:54:28 | David Rolfe Comments on Edwards Lifesciences

2019-04-15 17:02:15 | David Rolfe's Wedgewood Partners 1st-Quarter 2019 Client Letter

2019-04-09 11:04:57 | Did The Underlying Business Drive Edwards Lifesciences's NYSE:EW Lovely 367% Share Price Gain?

2019-04-09 10:05:00 | Edwards Lifesciences To Host Earnings Conference Call On April 23, 2019

2019-04-05 09:17:00 | Why Edwards Lifesciences Gained 13% in March

2019-03-28 11:58:48 | Should You Avoid Edwards Lifesciences Corporation EW?

2019-03-28 10:42:02 | Can Retail Pharmacy USA Lift Walgreens' WBA Q2 Earnings?

2019-03-26 10:32:09 | Do Directors Own Edwards Lifesciences Corporation NYSE:EW Shares?

2019-03-22 10:52:02 | Should John Hancock Multifactor Mid Cap ETF JHMM Be on Your Investing Radar?